- Home
- NVR vs BAX Comparison
NVR vs BAX Comparison
Compare NVR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVR
- BAX
- Stock Information
- Founded
- NVR 1980
- BAX 1931
- Country
- NVR United States
- BAX United States
- Employees
- NVR N/A
- BAX N/A
- Industry
- NVR Homebuilding
- BAX Medical/Dental Instruments
- Sector
- NVR Consumer Discretionary
- BAX Health Care
- Exchange
- NVR Nasdaq
- BAX Nasdaq
- Market Cap
- NVR 20.8B
- BAX 17.3B
- IPO Year
- NVR N/A
- BAX N/A
- Fundamental
- Price
- NVR $7,021.19
- BAX $30.24
- Analyst Decision
- NVR Buy
- BAX Buy
- Analyst Count
- NVR 4
- BAX 9
- Target Price
- NVR $9,023.33
- BAX $38.56
- AVG Volume (30 Days)
- NVR 25.2K
- BAX 5.1M
- Earning Date
- NVR 04-22-2025
- BAX 05-01-2025
- Dividend Yield
- NVR N/A
- BAX 2.24%
- EPS Growth
- NVR 1.37
- BAX N/A
- EPS
- NVR 486.51
- BAX N/A
- Revenue
- NVR $10,742,590,000.00
- BAX $10,636,000,000.00
- Revenue This Year
- NVR N/A
- BAX $6.38
- Revenue Next Year
- NVR $4.52
- BAX $4.13
- P/E Ratio
- NVR $14.53
- BAX N/A
- Revenue Growth
- NVR 9.09
- BAX 2.66
- 52 Week Low
- NVR $6,562.85
- BAX $26.25
- 52 Week High
- NVR $9,964.77
- BAX $40.96
- Technical
- Relative Strength Index (RSI)
- NVR 46.96
- BAX 48.51
- Support Level
- NVR $7,007.57
- BAX $27.52
- Resistance Level
- NVR $7,369.81
- BAX $30.48
- Average True Range (ATR)
- NVR 291.07
- BAX 1.46
- MACD
- NVR 8.47
- BAX 0.26
- Stochastic Oscillator
- NVR 65.55
- BAX 87.31
About NVR NVR Inc.
NVR Inc is a United States-based homebuilding company. It builds single-family detached homes, townhomes, and condominium buildings under three brands, Ryan Homes, NVHomes, and Heartland Homes. The company through its subsidiary also operates a mortgage banking and title services business. The homebuilding segment includes four geographic areas of the Mid-Atlantic, North East, Mid-East, and South East.
About BAX Baxter International Inc.
Baxter International Inc offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.